OXFORDWINSTON · The effects of lineage differentiation into pancreatic beta-cells on the immunogenicity of amniotic fluid stem cells
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2008-06-01 → 2011-05-31
- Финансиране от ЕС
- 333 819 €
- Участници
- 1
- Схема
- MC-IOF
Линиите свързват координатора с партньорите.
Накратко на български
Биоинженерните скелета от свински бъбреци се тестват, за да се разбере как имунната система реагира на имплантирането им. Това помага да се разбере как се развива възпалението и как тялото приема чуждите биоматериали.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Periodic Report Summary - OXFORDWINSTON (The effects of lineage differentiation into pancreatic beta-cells on the immunogenicity of amniotic fluid stem cells)
Dr Orlando has conceived, designed and implemented a ground-breaking project on ex vivo kidney bioengineering. Porcine kidneys are harvested and decellularised with detergents to produce renal extracellular matrix scaffolds. These constructs represent the ideal platform for kidney bioengineering. However, it is important to understand how the immune system reacts following the implantation of such scaffolds. To address this issue, while in Oxford, Dr Orlando has conceived and developed an experimental model for the characterisation of such response. The question to answer was whether inflammasome drives the inflammatory response which follows the implantation of bioengineered ECM, via the IL-1b signalling pathway. The immune system responds to the implantation of bioengineered constructs with a nonspecific inflammatory response orchestrated by the innate compartment. Regardless of the site of implantation, the first relevant event of this process is the contact between biomaterials and whole blood, which follows the haemorrhage caused by the incision. Thereafter, activation of the coagulation, contact and complement systems follows in a domino effect, with the consequent release of myriads of molecules, and the recruitment of cellular elements that altogether will mount the initial acute inflammatory response. As implanted biomaterials are intended to remain in situ indefinitely or until degradation, they tend to generate a foreign body reaction-like response. In fact, in the presence of a persisting stimulus represented by permanent biomaterials, the acute inflammatory response generated by the initial injury to the vascularised connective tissue is destined to perpetuate and evolve, as different cells are recruited over time and the predominant cell type present in the inflammatory milieu varies with the age of the injury. As robust data show that the key molecule in sterile inflammation is interleukin-1b, whose transcription is mediated by the inflammasome system, we developed a murine model to investigate the role of inflammasome in the response to the implantation of acellular murine liver extracellular matrix (alECM). Preliminary RT-PCR results obtained during 12-month research period at the transplant research immunology group at the University of Oxford, show that the implantation of aECM does trigger an inflammatory response in WT, TLR4-/- and RAG-/- mice, comparable to the one observed after the implantation of samples of whole liver.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
The use of stem cells for curing disease and ending disabilities may change the medical treatment in this century. However, there are some major roadblocks that need to be resolved before these cells are implemented in ordinary medical care. There are serious ethical issues regarding the use of embryonic stem cells, reliable methods for isolation and expansion of stem cells need to be established, stem cell plasticity raises the issue of tumorigenicity, the use of stem cell transplantation might encounter with rejection and more information is needed on stem cell immunogenicity. This proposal aims to address some of these roadblocks. Replacement of β-cells by transplantation of pancreatic islets has become a viable option for the treatment of certain patients with unstable Type 1 diabetes mellitus. However, the current supply of islets from pancreata of organ donors is very limited. Stem cells may serve as a new source of β-cells. Although promising results have been reported in the production of β-like cells from human embryonic stem cells, the process appears relatively inefficient. We have described the isolation of a novel class of human amniotic fluid stem (AFS) cells and showed that they are capable of extensive clonal expansion and can give rise to differentiated cell types derived from all three embryonic germ layers, but do not form teratoma tumors. Experiments with mouse AFS cells show that, when we forced the expression of the pancreatic transcription factor PDX-1, the cells can be induced to form islet-like clusters containing a high proportion of cells that synthesize proinsulin and display glucose-stimulated insulin secretion. Studies with human AFS (hAFS) cells have confirmed that they can express mRNA for critical beta-cell lineage functions. However, in the clinical scenario hAFS cells will face potential alloimmune responses including autoimmunity.
Оригинален текст от CORDIS (на английски).
Участници
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordКоординаторОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
